These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 27048505)
1. MicroRNA-143 inhibits IL-13-induced dysregulation of the epidermal barrier-related proteins in skin keratinocytes via targeting to IL-13Rα1. Zeng YP; Nguyen GH; Jin HZ Mol Cell Biochem; 2016 May; 416(1-2):63-70. PubMed ID: 27048505 [TBL] [Abstract][Full Text] [Related]
2. CYT387, a Novel JAK2 Inhibitor, Suppresses IL-13-Induced Epidermal Barrier Dysfunction Via miR-143 Targeting IL-13Rα1 and STAT3. Zu Y; Chen XF; Li Q; Zhang ST Biochem Genet; 2021 Apr; 59(2):531-546. PubMed ID: 33190168 [TBL] [Abstract][Full Text] [Related]
3. Rapamycin blocks the IL-13-induced deficiency of Epidermal Barrier Related Proteins via upregulation of miR-143 in HaCaT Keratinocytes. Jia QN; Zeng YP Int J Med Sci; 2020; 17(14):2087-2094. PubMed ID: 32922169 [TBL] [Abstract][Full Text] [Related]
4. Benvitimod upregulates filaggrin, involucrin and loricrin expressions via aryl hydrocarbon receptor-OVO-like 1 axis. Jia Q; Liu P; Wang X; Hu J; Jia J; Zhang J; Li H Arch Dermatol Res; 2024 Aug; 316(8):585. PubMed ID: 39207509 [TBL] [Abstract][Full Text] [Related]
5. (S)-(-)-blebbistatin O-benzoate has the potential to improve atopic dermatitis symptoms in NC/Nga mice by upregulating epidermal barrier function and inhibiting type 2 alarmin cytokine induction. Sahara S; Ueno A; Wakita N; Iwai M; Uda J; Nakaoji K; Hamada K; Maeda A; Kaneda Y; Fujimoto M PLoS One; 2024; 19(5):e0302781. PubMed ID: 38713650 [TBL] [Abstract][Full Text] [Related]
6. An Interleukin-4 and Interleukin-13 Induced Atopic Dermatitis Human Skin Equivalent Model by a Skin-On-A-Chip. Kim K; Kim H; Sung GY Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216228 [TBL] [Abstract][Full Text] [Related]
7. GATA3 regulates FLG and FLG2 expression in human primary keratinocytes. Zeitvogel J; Jokmin N; Rieker S; Klug I; Brandenberger C; Werfel T Sci Rep; 2017 Sep; 7(1):11847. PubMed ID: 28928464 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of interleukin-13 receptor alpha1 on human keratinocytes in the skin of psoriasis and atopic dermatitis. Wongpiyabovorn J; Suto H; Ushio H; Izuhara K; Mitsuishi K; Ikeda S; Nakao A; Okumura K; Ogawa H J Dermatol Sci; 2003 Oct; 33(1):31-40. PubMed ID: 14527737 [TBL] [Abstract][Full Text] [Related]
9. The IL-13/periostin/IL-24 pathway causes epidermal barrier dysfunction in allergic skin inflammation. Mitamura Y; Nunomura S; Nanri Y; Ogawa M; Yoshihara T; Masuoka M; Tsuji G; Nakahara T; Hashimoto-Hachiya A; Conway SJ; Furue M; Izuhara K Allergy; 2018 Sep; 73(9):1881-1891. PubMed ID: 29528494 [TBL] [Abstract][Full Text] [Related]
10. Methyl-β-cyclodextrin treatment combined to incubation with interleukin-4 reproduces major features of atopic dermatitis in a 3D-culture model. do Nascimento Pedrosa T; De Vuyst E; Mound A; Lambert de Rouvroit C; Maria-Engler SS; Poumay Y Arch Dermatol Res; 2017 Jan; 309(1):63-69. PubMed ID: 27833999 [TBL] [Abstract][Full Text] [Related]
11. Keratinocytes activated by IL-4/IL-13 express IL-2Rγ with consequences on epidermal barrier function. Progneaux A; Evrard C; De Glas V; Fontaine A; Dotreppe C; De Vuyst E; Nikkels AF; García-González V; Dumoutier L; Lambert de Rouvroit C; Poumay Y Exp Dermatol; 2023 May; 32(5):660-670. PubMed ID: 36645024 [TBL] [Abstract][Full Text] [Related]
12. Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis. Furue M Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751111 [TBL] [Abstract][Full Text] [Related]
13. Diosmin restores the skin barrier by targeting the aryl hydrocarbon receptor in atopic dermatitis. Lee J; Song KM; Jung CH Phytomedicine; 2021 Jan; 81():153418. PubMed ID: 33302042 [TBL] [Abstract][Full Text] [Related]
14. The "Alarmins" HMBG1 and IL-33 Downregulate Structural Skin Barrier Proteins and Impair Epidermal Growth. Nygaard U; van den Bogaard EH; Niehues H; Hvid M; Deleuran M; Johansen C; Vestergaard C Acta Derm Venereol; 2017 Mar; 97(3):305-312. PubMed ID: 27868148 [TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus inhibits terminal differentiation of normal human keratinocytes by stimulating interleukin-6 secretion. Son ED; Kim HJ; Park T; Shin K; Bae IH; Lim KM; Cho EG; Lee TR J Dermatol Sci; 2014 Apr; 74(1):64-71. PubMed ID: 24398033 [TBL] [Abstract][Full Text] [Related]
16. Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice. Wang Z; Zhang LJ; Guha G; Li S; Kyrylkova K; Kioussi C; Leid M; Ganguli-Indra G; Indra AK PLoS One; 2012; 7(12):e51262. PubMed ID: 23284675 [TBL] [Abstract][Full Text] [Related]
17. Topical Glucose Induces Claudin-1 and Filaggrin Expression in a Mouse Model of Atopic Dermatitis and in Keratinocyte Culture, Exerting Anti-inflammatory Effects by Repairing Skin Barrier Function. Yamada K; Matsushita K; Wang J; Kanekura T Acta Derm Venereol; 2018 Jan; 98(1):19-25. PubMed ID: 28967978 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-4 Downregulation of Involucrin Expression in Human Epidermal Keratinocytes Involves Stat6 Sequestration of the Coactivator CREB-Binding Protein. Bao L; Alexander JB; Zhang H; Shen K; Chan LS J Interferon Cytokine Res; 2016 Jun; 36(6):374-81. PubMed ID: 26918372 [TBL] [Abstract][Full Text] [Related]
19. MAP17 is associated with the T-helper cell cytokine-induced down-regulation of filaggrin transcription in human keratinocytes. Noh M; Yeo H; Ko J; Kim HK; Lee CH Exp Dermatol; 2010 Apr; 19(4):355-62. PubMed ID: 19601982 [TBL] [Abstract][Full Text] [Related]
20. Decreased expression of filaggrin in atopic skin. Seguchi T; Cui CY; Kusuda S; Takahashi M; Aisu K; Tezuka T Arch Dermatol Res; 1996 Jul; 288(8):442-6. PubMed ID: 8844122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]